We postulate that the relatively insufficient insulin secretion in this subgroup may be partly attributable to glucotoxicity and lipotoxicity, given the uncontrolled hyperglycaemia, overt dyslipidaemia and abnormal lipidomics profile. This evidence concerns the gene INS and Hyperglycemia.